A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.
Endothelin A (ET-A) receptor antagonists including zibotentan and atrasentan, have been suggested as a treatment for castration-resistant prostate cancer (CRPC). Our aim was to conduct a meta-analysis and indirect comparison to assess the efficacy and safety of ET-A receptor antagonists for treatmen...
Main Authors: | Ping Qi, Ming Chen, Li-xiu Zhang, Rui-xia Song, Zhen-hua He, Zhi-ping Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4508042?pdf=render |
Similar Items
-
The Synthetic Studies of The Endothelin Receptor Antagonists
by: Pan, Jee-Chuan, et al.
Published: (1997) -
Inhibition of castration resistant prostate cancer by sintokamide A : an antagonist of the amino-terminus of the androgen receptor
by: Tavakoli, Iran
Published: (2012) -
Inhibition of castration resistant prostate cancer by sintokamide A : an antagonist of the amino-terminus of the androgen receptor
by: Tavakoli, Iran
Published: (2012) -
Inhibition of castration resistant prostate cancer by sintokamide A : an antagonist of the amino-terminus of the androgen receptor
by: Tavakoli, Iran
Published: (2012) -
Iontophoresis of endothelin receptor antagonists in rats and men.
by: Matthieu Roustit, et al.
Published: (2012-01-01)